| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Aug 10, 2024 | 2 | $0 | 4 | Aug 13, 2024 | Director |
| NEO | NEOGENOMICS INC | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 25, 2024 | 2 | $0 | 4 | May 29, 2024 | Director |
| NEO | NEOGENOMICS INC | Aug 10, 2023 | 2 | $0 | 4 | Aug 14, 2023 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 26, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Director |
| CTMX | CytomX Therapeutics, Inc. | Jul 19, 2022 | 2 | -$7.97K | 4 | Jul 21, 2022 | Chief Medical Officer |
| NEO | NEOGENOMICS INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 20, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
| CTMX | CytomX Therapeutics, Inc. | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | Chief Medical Officer |
| CTMX | CytomX Therapeutics, Inc. | Oct 24, 2021 | 2 | $0 | 4 | Oct 26, 2021 | Chief Medical Officer |
| NEO | NEOGENOMICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 19, 2021 | 2 | $0 | 4 | May 21, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 14, 2021 | 0 | $0 | 3 | May 18, 2021 | Director |